Correspondence 0001493152-23-005804 from MANGOCEUTICALS, INC. (MGRX)

MANGOCEUTICALS, INC.
Date: Feb. 22, 2023 · CIK: 0001938046 · Accession: 0001493152-23-005804

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-269240

Date

February 10, 2023

Author

Securities, LLC

Form

CORRESP

Company

MANGOCEUTICALS, INC.

Letter

Re:

February 22, 2023

VIA EDGAR

Division of Corporation Finance

U.S. Securities & Exchange Commission

F Street, NE

Washington, DC 20549

Attn: Office of Industrial Applications and Services

Withdrawal of Acceleration Request of Mangoceuticals, Inc.

Registration Statement on Form S-1

File No. 333-269240

Ladies and Gentlemen:

Reference is made to our letter, filed as correspondence via EDGAR on February 10, 2023, in which we, as representative of the several underwriters of Mangoceuticals, Inc.’s proposed public offering, joined Mangoceuticals, Inc.’s request for acceleration of the effective date of the above-referenced Registration Statement for 4:00 p.m. Eastern time on Tuesday, February 14, 2023, or as soon thereafter as practicable. Mangoceuticals, Inc. is no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date.

[Signature page follows]

Very
truly yours,
Boustead
Securities, LLC

Show Raw Text

CORRESP
1
filename1.htm

February
22, 2023

VIA
EDGAR

Division
of Corporation Finance

U.S.
Securities & Exchange Commission

100
F Street, NE

Washington,
DC 20549

Attn:
Office of Industrial Applications and Services

    Re:

    Withdrawal
    of Acceleration Request of Mangoceuticals, Inc.

    Registration
    Statement on Form S-1

    File
    No. 333-269240

Ladies
and Gentlemen:

Reference
is made to our letter, filed as correspondence via EDGAR on February 10, 2023, in which we, as representative of the several underwriters
of Mangoceuticals, Inc.’s proposed public offering, joined Mangoceuticals, Inc.’s request for acceleration of the effective
date of the above-referenced Registration Statement for 4:00 p.m. Eastern time on Tuesday, February 14, 2023, or as soon thereafter as
practicable. Mangoceuticals, Inc. is no longer requesting that such Registration Statement be declared effective at this time and we
hereby formally withdraw our request for acceleration of the effective date.

[Signature
page follows]

    Very
truly yours,

    Boustead
    Securities, LLC

    By:
    /s/
    Keith Moore

    Name:
    Keith
    Moore

    Title:
    CEO

    As
    representative of the underwriters

SecProbe.io